TRANSGENE (EPA:TNG) | Finanzwire

Basculer en Français

10793	Companies
233179	Keywords
161779	Articles
124387	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 05/22/2025 at 17:45, 1 year 2 months ago

Transgene to Present 24-month Disease-Free Survival Data from All Patients in Phase I Part of Trial of Individualized Cancer Vaccine, TG4050, at ASCO 2025
Transgene to present 24-month disease-free survival data from all patients in Phase I part of trial of individualized cancer vaccine, TG4050, at ASCO 2025

Cancer Vaccine Transgene TG4050 ASCO 2025 Disease-free Survival
BRIEF

published on 04/10/2025 at 20:20, 1 year 3 months ago

Transgene makes available the 2024 Universal Registration Document

AMF Social Responsibility Immunotherapy Registration Document Transgene
PRESS RELEASE

published on 04/10/2025 at 20:15, 1 year 3 months ago

Availability of Transgene’s 2024 Universal Registration Document (URD)
Transgene announces availability of its 2024 Universal Registration Document (URD) containing financial reports and ESG factors. French & English versions can be accessed online

Financial Reports Transgene ESG Factors 2024 Universal Registration Document French Version
BRIEF

published on 03/27/2025 at 17:50, 1 year 4 months ago

Transgene: major advances and outlook for 2025

Immunotherapy Head And Neck Cancer 2024 Financial Results TG4050 Vaccine Myvac® Platform
PRESS RELEASE

published on 03/27/2025 at 17:45, 1 year 4 months ago

Transgene Achieves Key Milestones in 2024, Including Clinical Proof of Principle for Individualized Cancer Vaccine ? Strong Outlook for 2025
Transgene achieves key milestones in 2024, including clinical proof of principle for individualized cancer vaccine TG4050, with strong outlook for 2025. New trial planned in Q4 2025 for a second indication

Milestones Cancer Vaccine Transgene 2025 Outlook Clinical Proof
BRIEF

published on 01/21/2025 at 17:50, 1 year 6 months ago

Transgene Prepares for Biomed Investor Forum

Investors BIOMED Forum Immunotherapy Transgene Viral Vectors
PRESS RELEASE

published on 01/21/2025 at 17:45, 1 year 6 months ago

Transgene to Participate in the Biomed Forum Investor Conference
Transgene's management team to participate in the Biomed Forum Investor Conference in Paris on February 4, 2025

Investor Conference Paris BIOMED Forum Transgene February 4
BRIEF

published on 11/05/2024 at 07:35, 1 year 8 months ago

Transgene and ProBioGen join forces for personalized cancer vaccines

Biotechnology Cancer Transgene ProBioGen Personalized Vaccines
PRESS RELEASE

published on 10/14/2024 at 07:30, 1 year 9 months ago

Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers
BRIEF

published on 09/14/2024 at 09:10, 1 year 10 months ago

Transgene and BioInvent: promising results for the oncolytic virus BT-001

Cancer Transgene Oncolytic Virus BioInvent BT-001

Accesswire

Published on 08/01/2026 at 01:20, 1 day 22 hours ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 22 hours ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 23 hours ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/01/2026 at 00:25, 1 day 23 hours ago

BioNxt Solutions Announces Option Grants
Published on 07/31/2026 at 23:20, 2 days ago

Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.

View all ACCESSWIRE

EQS Group

Published on 08/03/2026 at 00:05, 8 minutes ago

Publication of the result of the voluntary public tender offer for all Addiko shares
Published on 08/02/2026 at 08:15, 15 hours 58 minutes ago

Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 1 day 7 hours ago

HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 2 days 4 hours ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 2 days 5 hours ago

Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project

Les Echos

Published on 07/31/2026 at 21:00, 2 days 3 hours ago

Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 2 days 4 hours ago

Share retention commitments (Dutreil Agreement)
Published on 07/31/2026 at 19:14, 2 days 4 hours ago

2026 First-Half financial report
Published on 07/31/2026 at 19:13, 2 days 5 hours ago

Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 2 days 5 hours ago

Covivio Hotels - 2026 Half-year financial report

View all LES ECHOS COMFI WIRE